Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about European projects that are funded by European programmes including FP7, H2020, IMI, JNPD, AAL and EU Health.

Filters

(Clear all)

affecTive basEd iNtegrateD carE for betteR Quality of Life

TeNDER

With an increasingly growing population in Europe, cognitive impairments as well as heart diseases are a major social and health issue. 1.2 million people in Europe are affected by Parkinson's disease (PD) while Alzheimer’s disease remains one of the biggest global public health challenges our generation is facing, while Cardiovascular disease...
Funding Programme
Start Date
End Date
Total Funding
€ 5 698 333
European Countries Involved

Artificial Intelligence for early and accurate neuropsychiatric diagnosis

NeuroPsyCAD

NeuroPsyCAD is a cloud-based reporting service that provides an accurate and early diagnosis of neuropsychiatric disorders. To achieve high accuracies, NeuroPsyCAD statistically compares a brain scan of a patient with a normative, human, and population representative database using machine-learning algorithms. It also analyses the brain as a whole...

Funding Programme
Start Date
End Date
Total Funding
€ 71 429
European Countries Involved

BEHAVIOUR PATTERN BASED ASSISTANT FOR THE EARLY DETECTION AND MANAGEMENT OF NEURODEGENERATIVE DISEASES

BEDMOND

The BEDMOND project aims at developing an ICT-based system for an early detection of  Alzheimer’s disease and other neurodegenerative diseases, based on a behavioural change to approach and focused in elderly people while living at home in an Ambient Assisted Living  environment. With such an early detection health professionals can later on apply...

Funding Programme
Start Date
End Date
Total Funding
€ 2 379 179
European Countries Involved

Biomarker based diagnosis of rapid progressive dementias – optimisation of diagnostic protocols.

DEMTEST

DEMTEST has established a large European and global collaboration between national surveillance units and dementia research centres, facilitating cooperation between neurologists, neuropathologists and neuroscientists. We work on standardisation of tests that are currently available and harmonise their use between centers worldwide. We define...
Funding Programme
Start Date
End Date
Total Funding
€ 2 200 000

Biomarkers for Alzheimer’s disease and Parkinson’s disease.

BIOMARKAPD

Neurodegenerative disorders, represented mostly by Alzheimer's disease (AD) and Parkinson's disease (PD), are characterised by progressive neuronal impairment and death. In spite of the brain's known capacity for regeneration, lost neurons generally cannot be replaced. Therefore, drugs aimed at inhibiting neurodegenerative processes are likely to...

Funding Programme
Start Date
End Date
Total Funding
€ 449 066

CARELINK for People with Dementia and their community

CARE-LINK

The objective of CARELINK is to deliver a tracking solution that addresses the issue of wandering in People with Dementia (PwD), allowing carers to monitor PwD. Using current machine-learning technologies we will profile user routes that can then be used to build a repository of route patterns to be compared against live routes, thus allowing for...

Funding Programme
Start Date
End Date
Total Funding
€ 2 282 944
European Countries Involved

Diagnostic and Drug Discovery Initiative for Alzheimer’s Disease

D3i4AD

Alzheimer’s disease (AD) is the major cause of dementia which has no cure at the moment. The overall aim of the work described in this proposal is to create a long-term strategic partnership between Sheffield University (UK), Lisbon University (Portugal), Eli Lilly (UK) and Biofordrug (Italy) in order to develop chemical biology tools for better...
Funding Programme
Start Date
End Date
Total Funding
€ 2 208 898
European Countries Involved

European Medical Information Framework

EMIF

In response to the need to tackle increasingly complex medical research questions, a growing amount of human health data is being collected, either in routine Electronic Healthcare Record (EHR) databases, through research-driven cohort studies, in biobanks or related efforts. However, data sources are typically fragmented and contain information...
Funding Programme
Start Date
End Date
Total Funding
€ 53 642 677

European Patient Organizations in Knowledge Society

EPOKS

The last two decades have witnessed the increasing role of patient, user and civil society organizations (POs and CSOs) in the production of knowledge on diseases and health problems. Rich and detailed studies have shown that this phenomenon entails new forms of activism. It also questions the modes of governance of knowledge, as well as the role...
Funding Programme
Start Date
End Date
Total Funding
€ 1 129 013
European Countries Involved

INNOVATIVE WATER-SOLUBLE PHYTOMATERIAL INHIBITORs FOR ALZHEIMERs AND PARKINSONs DISEASES PREVENTION

PhytoAPP

Under PhytoAPP project it is expected to build new and enhance existing network of international and inter-sectoral cooperation in the form of joint research and innovation activities between the project Partners with multidisciplinary skills and complementary competences in nanomaterials, physics, engineering, green chemistry, biochemistry and...
Funding Programme
Start Date
End Date
Total Funding
€ 1 021 200
European Countries Involved

Integration of AAL Components for Innovative Care Pathways

IntegrAAL

Internet-based and micro technologies have changed the way we live. But elderly people receiving care have not always benefited from these developments. IntegrAAL uses technology to help improve care for older people. Older people are often cared for by many different people, known as a circle of care. This circle may include informal carers as...
Funding Programme
Start Date
End Date
Total Funding
€ 1 200 000
European Countries Involved

MRI based mapping of microscopic brain composition in a mouse model of Alzheimer’s disease

uImaging

This project aims to establish a neuroimaging framework which informs about microscopic brain composition and apply it to study neurodegeneration in a genetic mouse model of Alzheimer’s disease (AD). AD is the most common cause of dementia, characterized by progressive neurodegenerative changes leading to a gradual cognitive loss and memory...
Funding Programme
Start Date
End Date
Total Funding
€ 159 815
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).